Lv5
1460 积分 2024-01-31 加入
Chidamide, a HDAC Inhibitor, Combined with Cladribine, High Dose Gemcitabine and Busulfan with Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory and Poor-Risk Lymphoma
4天前
已关闭
Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial: Results of an Interim Analysis
4天前
已关闭
Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial Expansion Phase: Impact of Prior Treatment and Expanded Safety Analysis
4天前
已完结
A Phase 2, Open-Label, Multicenter Study of Tazemetostat in Combination with Rituximab for the Treatment of Relapsed or Refractory Follicular Lymphoma
4天前
已关闭
A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myeloma
1个月前
已完结
Real-World Risk of Severe Cytopenias in Multiple Myeloma Patients Sequentially Treated with Immunomodulatory Drugs
1个月前
已完结
Intensified alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: primary outcomes from the randomized phase III OLIGO study
2个月前
已完结
Transformation of alkylating regimen of thiotepa into tepa determines the disease progression through GSTP1 gene polymorphism for metastatic breast cancer patients receiving thiotepa containing salvage chemotherapy
2个月前
已完结
Which drug would be more effective in treating patients with leptomeningeal metastases from breast cancer: intrathecal thiotepa or methotrexate?
2个月前
已完结
Vinorelbine thiotepa in metastatic breast cancer: a large real-life retrospective study
2个月前
已完结
皖公网安备34019202002308
